These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 2680158

  • 1. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
    Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Doherty J, Read R, Chesler E, Sako Y.
    Circulation; 1989 Nov; 80(5):1190-7. PubMed ID: 2680158
    [Abstract] [Full Text] [Related]

  • 2. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.
    Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Doherty J, Read R, Chesler E, Sako Y.
    Circulation; 1988 Jun; 77(6):1324-32. PubMed ID: 3286040
    [Abstract] [Full Text] [Related]

  • 3. Internal mammary artery and saphenous vein graft patency. Effects of aspirin.
    Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Kern KB, Sethi G, Sharma GV, Khuri S.
    Circulation; 1990 Nov; 82(5 Suppl):IV237-42. PubMed ID: 2225410
    [Abstract] [Full Text] [Related]

  • 4. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
    Stein PD, Dalen JE, Goldman S, Théroux P.
    Chest; 1998 Nov; 114(5 Suppl):658S-665S. PubMed ID: 9822069
    [Abstract] [Full Text] [Related]

  • 5. Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
    Chesebro JH.
    Thromb Res Suppl; 1990 Nov; 12():5-10. PubMed ID: 2082487
    [Abstract] [Full Text] [Related]

  • 6. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM, Nair U, Rees M, Saunders N, Walker D, Williams G, Critchley A, Beton D, Campbell C, Lawson RA.
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
    [Abstract] [Full Text] [Related]

  • 7. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy.
    Sethi GK, Copeland JG, Goldman S, Moritz T, Zadina K, Henderson WG.
    J Am Coll Cardiol; 1990 Jan; 15(1):15-20. PubMed ID: 2404046
    [Abstract] [Full Text] [Related]

  • 8. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G, Zheng Z, Pi Y, Lu B, Lu J, Hu S.
    J Am Coll Cardiol; 2010 Nov 09; 56(20):1639-43. PubMed ID: 21050973
    [Abstract] [Full Text] [Related]

  • 9. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
    Kulik A, Abreu AM, Boronat V, Kouchoukos NT, Ruel M.
    Contemp Clin Trials; 2018 May 09; 68():45-51. PubMed ID: 29551675
    [Abstract] [Full Text] [Related]

  • 10. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study.
    Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Kern KB, Sethi G, Sharma GV, Khuri S.
    Circulation; 1994 Mar 09; 89(3):1138-43. PubMed ID: 8124800
    [Abstract] [Full Text] [Related]

  • 11. Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting.
    Nocerino AG, Achenbach S, Taylor AJ.
    Am J Cardiol; 2013 Nov 15; 112(10):1576-9. PubMed ID: 24035160
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
    Willemsen LM, Janssen PWA, Hackeng CM, Kelder JC, Tijssen JGP, van Straten AHM, Soliman-Hamad MA, Deneer VHM, Daeter EJ, Sonker U, Klein P, Ten Berg JM.
    Am Heart J; 2020 Feb 15; 220():237-245. PubMed ID: 31884246
    [Abstract] [Full Text] [Related]

  • 13. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J, Brutel de la Rivière A, van Gilst WH, Hillege HL, Pfisterer M, Kootstra GJ, Dunselman PH, Mulder BJ, Lie KI.
    J Am Coll Cardiol; 1994 Nov 01; 24(5):1181-8. PubMed ID: 7930237
    [Abstract] [Full Text] [Related]

  • 14. Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group.
    Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Kern KB, Sethi G, Sharma GV, Khuri S.
    Circulation; 1991 Aug 01; 84(2):520-6. PubMed ID: 1860197
    [Abstract] [Full Text] [Related]

  • 15. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV, Khuri SF, Josa M, Folland ED, Parisi AF.
    Circulation; 1983 Sep 01; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [Abstract] [Full Text] [Related]

  • 16. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC).
    Sanz G, Pajarón A, Alegría E, Coello I, Cardona M, Fournier JA, Gómez-Recio M, Ruano J, Hidalgo R, Medina A.
    Circulation; 1990 Sep 01; 82(3):765-73. PubMed ID: 2203555
    [Abstract] [Full Text] [Related]

  • 17. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    Zhao Q, Zhu Y, Xu Z, Cheng Z, Mei J, Chen X, Wang X.
    JAMA; 2018 Apr 24; 319(16):1677-1686. PubMed ID: 29710164
    [Abstract] [Full Text] [Related]

  • 18. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
    Chesebro JH, Fuster V, Elveback LR, Clements IP, Smith HC, Holmes DR, Bardsley WT, Pluth JR, Wallace RB, Puga FJ.
    N Engl J Med; 1984 Jan 26; 310(4):209-14. PubMed ID: 6361561
    [Abstract] [Full Text] [Related]

  • 19. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis.
    Cataldo G, Heiman F, Lavezzari M, Marubini E.
    Coron Artery Dis; 1998 Jan 26; 9(4):217-22. PubMed ID: 9649928
    [Abstract] [Full Text] [Related]

  • 20. Influence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting.
    Zhu J, Zhu Y, Zhang M, Xue Q, Hu J, Liu H, Wang R, Wang X, Zhao Q.
    J Thorac Cardiovasc Surg; 2022 Mar 26; 163(3):1030-1039.e4. PubMed ID: 32359899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.